Development of radiation countermeasure agents for acute radiation syndromes

Animal Model Exp Med. 2023 Aug;6(4):329-336. doi: 10.1002/ame2.12339. Epub 2023 Aug 29.

Abstract

The risk of internal and external exposure to ionizing radiation (IR) has increased alongside the development and implementation of nuclear technology. Therefore, serious security issues have emerged globally, and there has been an increase in the number of studies focusing on radiological prevention and medical countermeasures. Radioprotective drugs are particularly important components of emergency medical preparedness strategies for the clinical management of IR-induced injuries. However, a few drugs have been approved to date to treat such injuries, and the related mechanisms are not entirely understood. Thus, the aim of the present review was to provide a brief overview of the World Health Organization's updated list of essential medicines for 2023 for the proper management of national stockpiles and the treatment of radiological emergencies. This review also discusses the types of radiation-induced health injuries and the related mechanisms, as well as the development of various radioprotective agents, including Chinese herbal medicines, for which significant survival benefits have been demonstrated in animal models of acute radiation syndrome.

Keywords: Chinese herbal medicines; essential medicines list; ionizing radiation; radiation countermeasure agents; radiation injury.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Radiation Syndrome* / drug therapy
  • Acute Radiation Syndrome* / prevention & control
  • Animals
  • Civil Defense*
  • Drugs, Essential*
  • Medical Countermeasures*
  • Radiation, Ionizing
  • Radiation-Protective Agents* / pharmacology
  • Radiation-Protective Agents* / therapeutic use

Substances

  • Drugs, Essential
  • Radiation-Protective Agents